Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Diana Medgyesy

Concepts (51)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antimetabolites, Antineoplastic
4
2003
105
0.150
 Why?
Fluorouracil
5
2013
235
0.130
 Why?
Tegafur
5
2003
12
0.090
 Why?
Colorectal Neoplasms
4
2000
848
0.080
 Why?
Deoxycytidine
5
2013
221
0.080
 Why?
Oxonic Acid
4
2003
13
0.080
 Why?
Camptothecin
2
2000
140
0.070
 Why?
Uracil
4
2000
36
0.070
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2013
1958
0.070
 Why?
Capecitabine
5
2013
57
0.060
 Why?
Pyridines
4
2003
605
0.050
 Why?
Breast Neoplasms
2
2013
2456
0.050
 Why?
Gastrointestinal Neoplasms
1
2003
70
0.050
 Why?
Prodrugs
2
1999
52
0.050
 Why?
Folic Acid Antagonists
1
1999
8
0.040
 Why?
Leucovorin
4
2000
101
0.040
 Why?
Oxidoreductases
1
1999
96
0.040
 Why?
Antineoplastic Agents
2
1999
2197
0.030
 Why?
Enzyme Inhibitors
1
1999
826
0.030
 Why?
Drug Combinations
3
2003
392
0.030
 Why?
Dose-Response Relationship, Drug
2
2013
2032
0.030
 Why?
Stomatitis
1
2013
16
0.020
 Why?
Administration, Oral
3
2000
848
0.020
 Why?
Niacinamide
1
2013
86
0.020
 Why?
Bevacizumab
1
2013
167
0.020
 Why?
Phenylurea Compounds
1
2013
112
0.020
 Why?
Skin Diseases
1
2013
149
0.020
 Why?
Disease-Free Survival
1
2013
769
0.020
 Why?
Drug Administration Schedule
1
2013
783
0.020
 Why?
Fatigue
1
2013
366
0.020
 Why?
Kaplan-Meier Estimate
1
2013
966
0.020
 Why?
Double-Blind Method
1
2013
2029
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2013
988
0.020
 Why?
Treatment Outcome
3
2013
11695
0.010
 Why?
Disease Progression
1
2013
2852
0.010
 Why?
Area Under Curve
1
2003
331
0.010
 Why?
Organoplatinum Compounds
1
2000
66
0.010
 Why?
Clinical Trials, Phase II as Topic
1
2000
77
0.010
 Why?
Clinical Trials, Phase III as Topic
1
2000
117
0.010
 Why?
Dihydrouracil Dehydrogenase (NADP)
1
1999
4
0.010
 Why?
Aged
2
2013
25947
0.010
 Why?
Humans
7
2013
144957
0.010
 Why?
Infusions, Intravenous
1
1998
423
0.010
 Why?
Middle Aged
2
2013
35928
0.010
 Why?
Adult
2
2013
40506
0.010
 Why?
Neoplasm Metastasis
1
1998
695
0.010
 Why?
Randomized Controlled Trials as Topic
1
2000
1721
0.010
 Why?
Female
3
2013
78376
0.010
 Why?
Time Factors
1
2003
7183
0.010
 Why?
Animals
2
1999
38109
0.000
 Why?
Male
2
2003
72406
0.000
 Why?
Medgyesy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (51) concept(s)
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)